COMP <GO>
NVCT vs BCAX // OPERATING MARGIN
Nuvectis Pharma Inc. (NASDAQ) VS. Bicara Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: NVCT 2
— BCAX 1
■ METRIC PARITY
LAST: $19.18 (+3.79%) • MKT CAP: $602.7M
operating-margins
—
LAST: $7.93 (-13.14%) • MKT CAP: $604.2M
operating-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NVCT VS. BCAX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NVCT | BCAX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.64% | -16.64% | +14.00 | NVCT | /fcf-yield <GO> |
| Operating Margin ACTIVE | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 2/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.5 | 20.5 | +21.00 | NVCT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $602.7M | $604.2M | -$1.5M | BCAX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NVCT REV | BCAX REV | NVCT GROSS % | BCAX GROSS % | NVCT FCF | BCAX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $77.2M | $435.7M | — | — | -$16.0M | -$107.1M |
| FY 2024 | $55.6M | $230.7M | — | — | -$12.2M | -$74.8M |
| FY 2023 | $64.1M | $111.7M | — | — | -$16.0M | -$45.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NVCT // BETA —
BCAX // BETA —